Skip to main content
Premium Trial:

Request an Annual Quote

A Year Ago: Aug 1, 2002


A year ago, GT’s cover story profiled New York-based ProteoMetrics, a software vendor using protein identification algorithms developed in chairman Brian Chait’s Rockefeller University lab. Times have definitely changed for the young company, which was shelled out by its collaborator, Genomic Solutions of Ann Arbor, Mich. The software became the foundation for Genomic Solutions’ new subsidiary, Proteomic Solutions, which was formerly the 11-person Winnipeg office of ProteoMetrics, headed up by once-CEO Ron Beavis. David Fenyo, the CSO and president of ProteoMetrics, joined Genomic Solutions as director of proteomics. Chait, meanwhile, returned to his Rockefeller lab, while the 40 New York-based employees of ProteoMetrics were sent packing.

The August 2001 issue also took readers on a tour of genomics hotbed North Carolina, which continues to lure companies and research with its heavy investments in the field. One feature looked at SAS spinout iBiomatics, located near Research Triangle Park in Cary. Since then, iBiomatics has spun back into SAS, and its bioinformatics products are sold now under the SAS brand. GT has looked at other RTP companies since then, including Saffron Technology, a data-mining company looking to get into the life sciences market.

— Amanda Urban

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.